This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
IRADIMED (IRMD) MRidium Magnetic MRI Gets FDA Approval
by Zacks Equity Research
IRADIMED CORPORATION (IRMD) recently announced the receipt of 510(k) clearance for its MRidium 3860+ magnetic MRI compatible IV infusion pump system, which features the Dose Error Reduction System software (DERS).
TransEnterix (TRXC) Opens New Surgical Robotics Facility
by Zacks Equity Research
TransEnterix (TRXC) announced that it would open a new surgical robotics facility in Milan, Italy.
Stryker (SYK) to Pay for Rejuvenate and ABG II Modular-Neck
by Zacks Equity Research
Stryker Corporation (SYK) announced that it has reached an agreement to compensate patients for Rejuvenate and ABG II Modular-Neck surgeries done prior to Dec 19, 2016.
Masimo's (MASI) TFA-1 Forehead Sensor Gets FDA Approval
by Zacks Equity Research
Masimo Corporation (MASI) recently announced that its TFA-1 Single-Patient-Use Adhesive Forehead Sensor has received a 5I0(k) clearance from the U.S. FDA.
PharMerica Amends Credit Facility, Ups Borrowing Capacity
by Zacks Equity Research
PharMerica Corporation (PMC) announced that it has amended its existing credit agreement.
Varian Expands in Croatia with Edge Radiosurgery Product
by Zacks Equity Research
Varian Medical Systems, Inc. (VAR) announced that its flagship product Edge Radiosurgery system is being installed at Croatia-based Radiochirurgia Zagreb Clinic.
Pacific Biosciences Terminates SMRT Agreement with Roche
by Zacks Equity Research
Pacific Biosciences of California, Inc. (PACB), announced that F. Hoffman-La Roche Ltd has chosen to terminate a preexisting development, commercialization and license agreement.
St. Jude Medical (STJ): EnSite Precision Gets FDA Clearance
by Zacks Equity Research
St. Jude Medical Inc. (STJ), a leading global medical device manufacturer, recently announced U.S. FDA approval for the EnSite Precision cardiac mapping system and Advisor FL Circular Mapping Catheter.
Baxter (BAX) to Acquire India-Based Claris Injectables
by Zacks Equity Research
Baxter International Inc. (BAX), a global medical technology company, has signed a definitive agreement to acquire Claris Lifesciences Limited???s subsidiary Claris Injectables Limited for almost $625 million.
St. Jude Medical: Proclaim Elite SCS System Now CE Marked
by Zacks Equity Research
St. Jude Medical Inc. (STJ), a leading global medical device manufacturer recently announced the CE mark approval for the full-body magnetic resonance (MR) conditional labeling of the Proclaim Elite Spinal Cord Stimulation (SCS) System.
Merit Medical Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of South Jordan, Utah-based Merit Medical Systems, Inc. (MMSI) reached a fresh 52-week high of $26.80 on Dec 9, finally closing a tad lower at $26.60.
West Pharma (WST) Hits 52-Week High on Growth Prospects
by Zacks Equity Research
Shares of West Pharmaceutical Services, Inc. (WST) reached a new 52-week high of $84.21 on Friday, Dec 9, 2016.
The Cooper Companies (COO) Beats Q4 Earnings Estimates
by Zacks Equity Research
The Cooper Companies Inc. (COO) reported adjusted earnings of $2.28 in fourth-quarter 2016, surpassing the Zacks Consensus Estimate by 4 cents and improving 14% on a year-over-year basis.
Integer (ITGR) to Co-Develop CCM Therapy with Impulse Dynamics
by Zacks Equity Research
Integer Holdings Corporation (ITGR) announced that it has signed a development agreement with Impulse Dynamics.
Ecolab (ECL) Rewards Shareholders with 6% Dividend Hike
by Zacks Equity Research
Ecolab Inc. (ECL) declared a quarterly cash dividend of 37 cents per share, reflecting a 6% increase from the previous payout.
ABIOMED Impella CP Gets Expanded FDA Approval, Stock Up
by Zacks Equity Research
Danvers, MA-based ABIOMED, Inc. (ABMD), a leading medical product developer, announced the expanded U.S. FDA pre-market approval (PMA) for the usage of Impella CP heart pump.
Top Ranked Momentum Stocks to Buy for December 8th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 8th:
Inogen (INGN) Affirms Outlook and Shuffles Top Management
by Zacks Equity Research
Inogen, Inc. (INGN) reiterated its fiscal 2016 outlook and appointed a new President cum Chief Executive Officer.
CryoLife (CRY) Now a Strong Buy: Should You Add the Stock?
by Zacks Equity Research
On Dec 6, Kennesaw, GA-based CryoLife Inc. (CRY) was raised to a Zacks Rank #1 (Strong Buy).
athenahealth-ADP Launch Cloud-Based Payroll for Hospitals
by Zacks Equity Research
athenahealth Inc (ATHN) recently introduced cloud-based payroll and attendance services for small hospitals in collaboration with Automatic Data Processing (ADP).
Luminex Awarded R&D 100 for ARIES Systems in November
by Zacks Equity Research
Luminex Corporation (LMNX) announced that its ARIES Systems was awarded the R&D 100 Award at the 54th Annual R&D 100 Awards ceremony in November.
Allscripts Buys Core Medical Solutions, Expands in Australia
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX), a leading global provider of information technology and services to healthcare organizations, recently announced the acquisition of Core Medical Solutions to expand its offerings in Australia.
Envision Healthcare Ties Up with Alabama Neonatal Medicine
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) announced the acquisition of Alabama Neonatal Medicine, P.C. and the extension of its Women's and Children's Services specialty.
Top Ranked Momentum Stocks to Buy for December 6th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 6th:
DaVita Ties Up With Inspira Health, Expands in South Jersey
by Zacks Equity Research
DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services in the U.S., announced a joint venture with Inspira Health Network to expand dialysis services at the Bridgeton, Millville and Vineland centers of South Jersey.